杰龙 GERN 深 沪
等待开盘 11-04 09:30:00 美东时间
1.225
-0.035
-2.78%
华盛通- 最 高1.29
- 今 开1.26
- 成交量 281.64万股
- 最 低 1.22
- 昨 收 1.26
- 总市值 7.82亿
- 52周最高 4.255
- 市盈率 静 --
- 换手率 0.44%
- 52周最低 1.09
- 委 比 5.32%
- 总股本 6.38亿
- 历史最高 7.79
- 量 比 2.10
- 振 幅 5.56%
- 历史最低 0.75
- 每 手 1
- 风险率 1.01%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Geron To Present New RYTELO Data On LR-MDS And Myelofibrosis At ASH 2025
New analysis from the Phase 3 IMerge clinical trial, accepted as an oral presentation, explores relationship between treatment-emergent cytopenias and clinical response in LR-MDSAdditional poster presentations include
11-03 22:11
优秀！永康籍运动员入围2026年米兰冬奥会主力阵容
（来源：永康人） 近日，记者从永康三中体育教师吕杨处获悉，其曾培养的学生叶杰龙，已入围2026年冬奥会男子四人雪车项目参赛名单。 叶杰龙...
10-30 09:03
Geron announces executive leadership changes, new appointments
Geron Corporation (NASDAQ:GERN) on Monday said it will make several executive leadership changes this month as part of a restructuring to align with its commercial priorities. Chief Operating Officer ...
10-14 04:44
Geron's COO Andrew Grethlein To Depart On October 15, 2025
FOSTER CITY, Calif., Oct. 13, 2025 (GLOBE NEWSWIRE) -- Geron Corporation (NASDAQ:GERN), a commercial-stage biopharmaceutical company aiming to change lives by changing the course of blood cancer, today announced several
10-14 04:42
Geron Corporation Announces Executive Leadership Transitions and Appointments
Geron Corporation has appointed four new executives to strengthen its leadership team, including Ahmed ElNawawi as Executive Vice President and Chief Commercial Officer, effective October 20, 2025. ElNawawi brings extensive experience in commercial leadership and oncology drug launches. Additionally, Shanthakumar Tyavanagimatt, Dawn Schottlandt, and Bryan Ridgell have joined as Senior Vice Presidents in technical operations, investor relations, a...
10-13 20:34
“易中天”领头羊，董事长又套现了37亿
近3年股价翻了40倍，股价在牛市里继续狂飙，董事长却又又又套现了。 国庆节前，9月30日晚，“易中天”的领头羊、光模块龙头新易盛披露，公司董事长高光荣计划通过...
10-10 19:41
Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Geron Corporation has granted equity awards totaling 966,000 shares to 16 new employees, including 644,000 stock options priced at $1.27 per share and 322,000 RSUs. The stock options vest over four years, with 12.5% after six months and the rest in equal quarterly installments. RSUs vest 25% annually over four years. The awards were granted under Nasdaq Rule 5635(c)(4) and the 2018 Inducement Award Plan. Geron is a biopharmaceutical company speci...
09-18 20:01
20250610中际旭创VS新易盛，光模块谁是老大？哪个更值得投资？
（来源：君实财经） 预警：本文超过一万字，仅仅是站在价值投资者的角度进行研究，请勿作为投资依据。 接上篇文章：中际旭创，股价腰斩的光模块龙头是否已跌到击球区？刚...
08-19 20:16
Geron taps Harout Semerjian as CEO
Geron (NASDAQ:GERN) has appointed Harout Semerjian as president and chief executive officer and a member of the board of directors, effective August 7,2025. Semerjian will succeed Dawn Carter Bir, who...
08-06 20:40
